**Therapy of human diseases with interleukins**

In the immunotherapy of melanoma and renal carcinoma have successfully been used interleukin-2 and interferon-gamma. Their mechanisms of action involve the activation of natural killer (NK) cells and T lymphocytes. The FDA has approved these 2 cytokines for the treatment of these 2 malignancies.